2015-12-18 | Downgrade | Ladenburg Thalmann | Buy to Neutral | |
2015-12-18 | Downgrade | William Blair | Outperform to Market Perform | |
2015-10-14 | Reiterated Rating | Wedbush | Neutral | $2.00 |
2015-09-16 | Initiated Coverage | Wedbush | Hold | $2.00 |
2015-05-18 | Initiated Coverage | Roth Capital | Buy | $5.00 |
2015-04-06 | Set Price Target | Wedbush | Hold | $2.00 |
2015-03-24 | Reiterated Rating | William Blair | Outperform | |
2015-03-16 | Reiterated Rating | Wedbush | Neutral | $2.00 |
2015-02-13 | Set Price Target | Wedbush | Hold | $2.00 |
2015-01-27 | Set Price Target | Wedbush | Hold | $2.00 |
2014-12-22 | Reiterated Rating | William Blair | Outperform | |
2013-05-10 | Upgrade | Ladenburg Thalmann | Neutral to Buy | $6 |
2012-04-16 | Upgrade | JMP Securities | Mkt Perform to Mkt Outperform | $3 |
2011-05-26 | Initiated | Global Hunter Securities | Accumulate | $5 |
2011-02-04 | Reiterated | Wedbush | Outperform | $7 to $5 |
2010-11-02 | Downgrade | Ladenburg Thalmann | Buy to Neutral | $14 to $2 |
2010-10-19 | Initiated | JMP Securities | Mkt Perform | |
2009-03-25 | Reiterated | Wedbush Morgan | Buy | $10 to $16 |
2009-03-25 | Reiterated | Ladenburg Thalmann | Buy | $9.50 to $14 |
2008-12-11 | Reiterated | Ladenburg Thalmann | Buy | $11 to $9.50 |
2008-11-20 | Reiterated | Cantor Fitzgerald | Buy | $33 to $15 |
2008-09-19 | Downgrade | Argus | Buy to Sell | |
2008-09-11 | Initiated | Oppenheimer | Perform | |
2008-09-08 | Reiterated | Ladenburg Thalmann | Buy | $23 to $11 |
2008-05-16 | Initiated | Cantor Fitzgerald | Buy | $33 |
2008-05-02 | Initiated | Pacific Growth Equities | Buy | |
2008-02-27 | Initiated | JP Morgan | Overweight | |
2008-02-25 | Initiated | Punk, Ziegel & Co | Buy | $23 |
2007-06-20 | Initiated | Banc of America Sec | Buy | $23 |
2015-12-18 | Downgrade | Ladenburg Thalmann | Buy to Neutral | |
2015-12-18 | Downgrade | William Blair | Outperform to Market Perform | |
2015-10-14 | Reiterated Rating | Wedbush | Neutral | $2.00 |
2015-09-16 | Initiated Coverage | Wedbush | Hold | $2.00 |
2015-05-18 | Initiated Coverage | Roth Capital | Buy | $5.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In BIOD 0 funds of 2213 total. Show all
Fund name | Ticker shares |
---|
Name Relationship | Total Shares | Holding stocks |
---|---|---|
PERCEPTIVE ADVISORS LLC | 7.03% (1595000) | ACRX / AEGR / ALDX / BIOD / FOLD / LJPC / PLCC / RPRX / VSAR / ZGNX / |
Steiner Solomon | 6.85% (1555026) | BIOD / |
Phase4 Partners Ltd | 4.70% (1065447) | BIOD / |
ASTRAZENECA PLC | 2.24% (508141) | BIOD / RGLS / |
DESOUZA ERROL B CEO | 0.70% (159416) | BIOD / PTN / TRGT / |
STEINER ERIK Vice-President, Operations | 0.35% (79545) | BIOD / |
MICHEL GERARD J CFO, VP of Corp and Dev/Treas | 0.19% (43810) | ASTM / BIOD / |
Krasner Alan Seth Chief Medical Officer | 0.16% (35687) | BIOD / |
SANDERS CHARLES A | 0.08% (19096) | BCRX / BIOD / LPDX / |
Bavier Paul S General Counsel/Corp. Sec. | 0.08% (18977) | BIOD / |
LIEBERMAN IRA | 0.05% (11292) | BIOD / |
Ginsberg Barry H | 0.03% (7669) | BIOD / |
LORBER DANIEL | 0.02% (5157) | BIOD / |
Casey Donald M Jr. | 0.01% (2969) | BIOD / CAH / WSTC / XRAY / |
URCIUOLI J ARTHUR | 0.01% (1969) | BIOD / |